샘플 요청 목록

 카트 문의
시장보고서
상품코드
1424992

세계 미생물 API 시장 : 숙주별, 유형별, 분자별, 사이트별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024년-2032년)

Microbial API Market, By Host, By Type, By Molecule, By Site, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 267 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

미생물 API 시장 규모는 2023년에 621억 9,600만 달러로 평가되었고 2024년부터 2032년까지 복합 연간 성장률(CAGR) 6.5%로 확대될 전망입니다

미생물 API 시장 - 시장 역학

생물학적 약제에 대한 수요 증가와 발효 과정을 이용한 시장 개척의 용이성이 시장 성장의 원동력이 될 전망

생물학적 제제는 생물 제제라고도 불리며, 생물 또는 그 성분으로부터 유래된 의약품입니다. 이러한 의약품은 보통 단백질, 항체, 핵산 등의 거대하고 복잡한 분자이며, 암, 자가면역질환, 감염증 등 다양한 질환의 치료에 사용됩니다. 바이오시밀러는 수년 전부터 미국 식품의약국(FDA)에 의해 승인되었지만, 많은 의료 전문가들에게는 여전히 비교적 새로운 의약품이며, 특히 당뇨병이나 안과와 같은 바이오시밀러가 최근 승인된 치료 분야에서 여전히 새로운 의약품입니다. 바이오시밀러 업계 전문가에 따르면 바이오시밀러는 2025년까지 미국 약비를 1,330억 달러 절감할 것으로 예측됩니다. 미생물 API라는 용어는 발효를 통해 미생물에서 유래된 제약 활성 성분(API)을 의미합니다. 이 미생물 API는 생물학적 약물의 주요 성분입니다. 게다가, 유전공학과 발효기술과 같은 생명공학의 진보는 미생물 원료의 생산 효율을 향상시키고 기술 혁신의 기회를 창출하고 있습니다. 그러나 규제 문제와 환경에 대한 우려는 시장 성장의 장애가 될 수 있습니다.

미생물 API 시장 - 주요 인사이트력

우리의 리서치 애널리스트가 공유한 분석에 따르면 세계 미생물 API 시장은 예측 기간(2024년-2032년)에 복합 연간 성장률(CAGR) 6.5%로 매년 성장할 것으로 추정됩니다.

숙주 세분화에 기초하여, 포유류는 2023년에 가장 큰 시장 점유율을 나타낼 것으로 예측됩니다.

유형별로는 2023년에는 항체가 주요 분자가 됩니다.

분자 세분화에 근거하여(2023년)에는 제네릭 의약품이 주요 분자였습니다.

사용 사이트별로는 2023년은 수탁 제조가 주요 분자였습니다.

최종 사용자 세분화에 근거하여(2023년) 주요 분자는 제약 회사였습니다.

지역별로는 아시아태평양이 2023년 주요 수익원이

미생물 API 시장 - 세분화 분석 :

세계 미생물 API 시장은 숙주, 유형, 분자, 사이트, 최종 사용자, 지역에 따라 세분화됩니다.

시장은 숙주에 따라 세 가지 범주로 나뉩니다. 포유류, 박테리아, 곰팡이. 시장의 성장을 견인하는 것은 포유류 부문의 이점입니다. 포유류 세포는 암이나 자가면역질환 등 다양한 질환의 치료에 널리 응용되고 있는 바이오의약품의 일종인 단클론항체(mAbs)의 제조에 널리 이용되고 있습니다.

시장은 유형별로 5가지로 분류된다: 항체, 펩티드, 단백질, 저분자, 백신입니다. 항체 부문은 시장을 독점합니다. 미생물 발현 시스템을 사용하면 특정 항체 단편의 생산에 비용면에서 유리합니다. 이는 비용에 대한 고려가 중요한 역할을 하는 제약 산업에서 특히 중요합니다.

시장은 분자에 의해 두 가지 범주로 나뉩니다: 혁신과 제네릭. 시장 성장의 주요 원동력은 제네릭 분자입니다. 제네릭 의약품에 이용되는 미생물 원약에 관해서는 활성 성분은 미생물 발효에 의해 제조할 수 있습니다. 이 방법은 특정 항생제 및 기타 치료 화합물의 제조에 널리 사용됩니다.

시장은 제조소에 의해 두 가지 범주로 나뉘어져 있습니다. 인하우스와 아웃소싱입니다. 아웃소싱 세분화이 시장을 독점하고 있습니다. 미생물 발현 시스템을 이용하면 특정 항체 단편을 생산할 때 비용 이점을 얻을 수 있습니다. 이것은 비용 요인이 큰 비중을 차지하는 제약 분야에서 특히 중요한 의미를 가지고 있습니다.

시장은 최종 사용자별로 제약기업, 바이오제약기업 등 3가지로 분류됩니다. 제약 회사는 시장에서 큰 점유율을 차지합니다. 미생물 원료 분야에 종사하는 기업은 발효 기술과 이러한 원료를 제조하기 위한 공정의 고도화에 관한 전문 지식을 가지고 있습니다. 이 회사들은 미생물 발효의 효과를 향상시키고 새로운 치료 화합물을 탐구하기 위해 연구 개발에 자원을 자주 할당합니다.

미생물 API 시장 - 지리적 인사이트

이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카를 포함한 다양한 지역으로 지리적으로 확산되고 있습니다. 이 지역은 사업 활동에 관여하는 국가에 따라 추가로 분할됩니다. 아시아태평양은 주로 생명을 위협하는 질병의 만연 증가와 건강 관리 인프라 개선으로 시장 성장에 지배적인 역할을 할 것으로 예상됩니다. 이 지역은 인구가 많이 다양성이 풍부하고 암, 당뇨병, 심혈관 장애 등의 질병 발생이 증가하고 있습니다. 세계보건기구(WHO)에 따르면 심혈관질환은 세계 사망의 1위로 매년 약 1,790만 명의 생명을 빼앗고 있습니다. 아시아태평양 많은 국가들은 현대 병원, 클리닉, 연구 기관 설립 등 건강 관리 인프라에 많은 투자를 해왔습니다. 특히 중국은 지난 20년간 헬스케어 지출이 대폭 증가하고 있으며 총 지출은 2021년 7조 6,000억 위안(약 1조 2,000억 달러)에 달하고, 2015년에서 2배 이상으로 증가 했습니다. 2021년 헬스케어 지출은 연간 GDP의 6.5%를 차지하고 2020년의 7.1%보다 약간 낮습니다. 반면에 북미와 유럽이 예상 기간 동안 시장 성장을 견인하는 것은 예상되는데, 그 이유는 지역 또는 지방 수준에서 강력한 제약 회사가 존재하기 때문입니다.

미생물 API 시장 - 경쟁 구도:

미생물 API 시장 경쟁 구도은 제약 회사, 제조 위탁 기관(CMO) 및 미생물 유래 유효 성분의 생산에 종사하는 다른 기업 간의 엄격한 경쟁을 특징으로합니다. 이 시장에서 주요 제약 회사는 종종 더 큰 시장 점유율을 얻기 위해 전문 CMO와 경쟁합니다. 이 업계의 경쟁은 주로 생산 기술의 혁신, 공정 최적화, 새롭고 독특한 미생물 균주의 개발로 인해 발생합니다. 효율성 향상과 생산 비용 절감을 위한 R&D를 선호하는 기업은 경쟁 우위를 확보할 수 있습니다. 예를 들어, 론자는 바이오 의약품의 제조 과정을 강화하기 위해 유전 공학에 중점을 두고 있습니다. 론자의 미생물 개발 서비스로 균주 개발과 셀 뱅킹의 책임자를 맡는 요아힘 클라인에 따르면 유전자 편집, 차세대 시퀀싱, 유전체학의 진보는 생산성이 높고 확장 가능한 생산 균주를 설계하는데 중요한 역할을 수행합니다.

목차

제1장 미생물 API 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 미생물 API의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 미생물 API 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀의 분석

제5장 미생물 API 시장 : COVID-19증의 영향 분석

  • 신형 코로나바이러스 감염증 이전의 영향 분석
  • 신형 코로나바이러스 감염증 후의 영향 분석

제6장 미생물 API 시장 상황

  • 미생물 API 시장 점유율 분석(2023년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 미생물 API 시장 - 숙주별

  • 개요
    • 숙주별 부문 점유율 분석
    • 포유류
    • 세균성
    • 곰팡이

제8장 미생물 API 시장 - 유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 항체
    • 펩티드
    • 단백질
    • 저분자
    • 백신

제9장 미생물 API 시장 - 분자별

  • 개요
    • 분자별 부문 점유율 분석
    • 혁신적
    • 제네릭

제10장 미생물 API 시장 - 사이트별

  • 개요
    • 부문 점유율 분석(사이트별)
    • 사내
    • 외부 위탁

제11장 미생물 API 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 제약회사
    • 바이오의약품기업
    • 기타

제12장 미생물 API 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제13장 주요 벤더 분석 - 미생물 API 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Merck &Co., Inc.
    • Topfond Pharmaceutical Co., Ltd.
    • DSM
    • CSPC Pharmaceutical Group Limited
    • KOLON LIFE SCIENCE
    • Shandong Lukang Pharmaceutical Co., Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Lonza
    • Others

제14장 애널리스트의 전방위 전망

BJH 24.02.26

REPORT HIGHLIGHT

Microbial API Market size was valued at USD 62,196 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Microbial APIs are pharmaceutical substances obtained from microorganisms, including bacteria, fungi, or yeast. In the pharmaceutical field, the term API refers to the active ingredient in a medication that produces the desired therapeutic effect. When referring to Microbial APIs, it generally pertains to pharmaceutical products or drugs derived from microorganisms. An example of this is the production of antibiotics by microorganisms. To demonstrate, the API range provides a standardized and concise version of existing identification techniques. Previously, these techniques were involved to execute and challenging to interpret. In the case of the API 20E, a plastic strip comprises twenty mini-test chambers with dehydrated media that possess chemically-defined compositions for each test. These tests primarily detect enzymatic activity, particularly associated with the fermentation of carbohydrates or the breakdown of proteins or amino acids by the microorganisms under examination.

Microbial API Market- Market Dynamics

The rising demand for biological drugs and the ease of their development using the fermentation process are expected to drive the growth of market

Biological drugs, also known as biologics, are pharmaceutical products that are derived from living organisms or their components. These drugs are typically large and complex molecules, such as proteins, antibodies, or nucleic acids, and they are used to treat various diseases, including cancer, autoimmune disorders, and infectious diseases. While biosimilars have been approved by the U.S. Food and Drug Administration (FDA) for several years now, they are still relatively new to many healthcare professionals, especially in therapeutic areas like diabetes and ophthalmology where biosimilars have only recently received approval. According to Biosimilars industry specialists, biosimilars are projected to reduce U.S. drug expenditure by USD 133 billion by 2025. The term Microbial API refers to the active pharmaceutical ingredients (APIs) that are derived from microorganisms through fermentation. These Microbial APIs are the key components of biological drugs. Furthermore, advancements in biotechnology, such as genetic engineering and fermentation technology, are improving the production efficiency of Microbial APIs and creating opportunities for innovation. However, regulatory challenges and environmental concerns may pose obstacles to the growth of the market.

Microbial API Market- Key Insights

As per the analysis shared by our research analyst, the global Microbial API market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

Based on Host segmentation, Mammalian was predicted to show maximum market share in the year 2023

Based on Type segmentation, Antibody was the leading Molecule in 2023

Based on Molecule segmentation, Generic was the leading Molecule in 2023

Based on Site segmentation, Outsourced was the leading Molecule in 2023

Based on end user segmentation, Pharmaceutical corporations was the leading Molecule in 2023

On the basis of region, Asia pacific was the leading revenue generator in 2023

Microbial API Market- Segmentation Analysis:

The Global Microbial API Market is segmented on the basis of Host, Type, Molecule, Site, End User, and Region.

The market is divided into three categories based on Host: Mammalian, Bacterial and Fungal. The market growth is driven by the dominance of mammalian segment. Mammalian cells are extensively utilized in the manufacturing of monoclonal antibodies (mAbs), a type of biopharmaceuticals that find widespread application in the treatment of diverse diseases such as cancer and autoimmune disorders.

The market is divided into five categories based on Type: Antibody, Peptide, Protein, Small Molecule and Vaccine. Antibody segment dominates the market. The use of microbial expression systems can offer cost advantages in the production of certain antibody fragments. This is particularly important in the pharmaceutical industry, where cost considerations play a significant role.

The market is divided into two categories based on Molecule: Innovative and Generic. The market growth is predominantly driven by a generic molecule. When it comes to Microbial APIs utilized in generic medications, the active component can be manufactured via microbial fermentation. This method is widely employed in the production of specific antibiotics and other therapeutic compounds.

The market is divided into two categories based on Site: In-House and Outsourced. Outsourced segment dominates the market. The utilization of microbial expression systems can provide cost benefits in manufacturing specific antibody fragments. This holds particular significance in the pharmaceutical sector, where cost factors hold substantial importance.

The market is divided into three categories based on End-User: Pharmaceutical Companies, Bio pharmaceutical Companies and Others. Pharmaceutical corporations hold a significant share in the market. Companies engaged in the Microbial API sector possess expertise in fermentation technology and the advancement of processes for manufacturing these APIs. These corporations frequently allocate resources towards research and development to improve the effectiveness of microbial fermentation and explore novel therapeutic compounds.

Microbial API Market- Geographical Insights

This market is geographically spread across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The Asia Pacific region is expected to have a dominant role in the market's growth, primarily due to the increasing prevalence of life-threatening diseases and the improvement of healthcare infrastructure. This region is home to a large and diverse population, and there is a rising occurrence of diseases such as cancer, diabetes, and cardiovascular disorders. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, claiming approximately 17.9 million lives each year. Many countries in the Asia Pacific region have made significant investments in healthcare infrastructure, including the establishment of modern hospitals, clinics, and research institutions. China, in particular, has witnessed substantial growth in healthcare spending over the past two decades, with total expenditure reaching RMB 7.6 trillion (approximately US$1.2 trillion) in 2021, more than doubling from 2015. In 2021, healthcare expenditure accounted for 6.5 percent of the annual GDP, slightly lower than the 7.1 percent recorded in 2020. On the other hand, the growth of the market in the forecast period is expected to be driven by North America and Europe, primarily due to the presence of strong pharmaceutical companies at the local or regional level.

Microbial API Market- Competitive Landscape:

The competitive landscape of the Microbial API market is characterized by severe competition among pharmaceutical companies, contract manufacturing organizations (CMOs), and other entities involved in the production of microbial-derived active ingredients. In this market, major pharmaceutical companies often find themselves competing with specialized CMOs to gain a larger market share. The competition in this industry is primarily driven by innovation in production technologies, process optimization, and the development of new and unique microbial strains. Companies that prioritize research and development to improve efficiency and reduce production costs are able to gain a competitive edge. For instance, Lonza has placed significant emphasis on genetic engineering to enhance its processes for the production of biotherapeutics. According to Joachim Klein, the head of strain development and cell banking for Lonza's microbial development services, advancements in genome editing, next-generation sequencing, and genomics play a crucial role in designing productive and scalable production strains.

Recent Developments:

In July 2023, Kinvan Private Limited, the first API fermentation unit, was set up in the Plassara Industrial Area of Nalagarh with an investment of USD 55.2 million (Rs 460 crore) to promote domestic manufacturing in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICROBIAL API MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck & Co., Inc.

Topfond Pharmaceutical Co., Ltd.

DSM

CSPC Pharmaceutical Group Limited

KOLON LIFE SCIENCE

Shandong Lukang Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

Lonza

Others

GLOBAL MICROBIAL API MARKET, BY HOST- MARKET ANALYSIS, 2019 - 2032

  • Mammalian
  • Bacterial
  • Fungal

GLOBAL MICROBIAL API MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antibody
  • Peptide
  • Protein
  • Small Molecule
  • Vaccine

GLOBAL MICROBIAL API MARKET, BY MOLECULE- MARKET ANALYSIS, 2019 - 2032

  • Innovative
  • Generic

GLOBAL MICROBIAL API MARKET, BY SITE- MARKET ANALYSIS, 2019 - 2032

  • In-House
  • Outsourced

GLOBAL MICROBIAL API MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others

GLOBAL MICROBIAL API MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Microbial API Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Microbial API Market Snippet by Host
    • 2.1.2. Microbial API Market Snippet by Type
    • 2.1.3. Microbial API Market Snippet by Molecule
    • 2.1.4. Microbial API Market Snippet by Site
    • 2.1.5. Microbial API Market Snippet by End User
    • 2.1.6. Microbial API Market Snippet by Country
    • 2.1.7. Microbial API Market Snippet by Region
  • 2.2. Competitive Insights

3. Microbial API Key Market Trends

  • 3.1. Microbial API Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Microbial API Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Microbial API Market Opportunities
  • 3.4. Microbial API Market Future Trends

4. Microbial API Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Microbial API Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Microbial API Market Landscape

  • 6.1. Microbial API Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Microbial API Market - By Host

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Host, 2023 & 2032 (%)
    • 7.1.2. Mammalian
    • 7.1.3. Bacterial
    • 7.1.4. Fungal

8. Microbial API Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 8.1.2. Antibody
    • 8.1.3. Peptide
    • 8.1.4. Protein
    • 8.1.5. Small Molecule
    • 8.1.6. Vaccine

9. Microbial API Market - By Molecule

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Molecule, 2023 & 2032 (%)
    • 9.1.2. Innovative
    • 9.1.3. Generic

10. Microbial API Market - By Site

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Site, 2023 & 2032 (%)
    • 10.1.2. In-House
    • 10.1.3. Outsourced

11. Microbial API Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Pharmaceutical Companies
    • 11.1.3. Biopharmaceutical Companies
    • 11.1.4. Others

12. Microbial API Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Microbial API Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Microbial API Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Microbial API Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Microbial API Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Microbial API Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Microbial API Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Merck & Co., Inc.
    • 13.2.2. Topfond Pharmaceutical Co., Ltd.
    • 13.2.3. DSM
    • 13.2.4. CSPC Pharmaceutical Group Limited
    • 13.2.5. KOLON LIFE SCIENCE
    • 13.2.6. Shandong Lukang Pharmaceutical Co., Ltd.
    • 13.2.7. Teva Pharmaceutical Industries Ltd.
    • 13.2.8. Lonza
    • 13.2.9. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제